Related Experiment Video
Updated: Jan 19, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis
Chia-Jung Li1,2, Pei-Yi Chu3,4,5, Giou-Teng Yiang6,7
1Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Abstract:
The transforming growth factor-β (TGF-β) signaling pathway plays multiple regulatory roles in the tumorigenesis and development of cancer. TGF-β can inhibit the growth and proliferation of epithelial cells and induce apoptosis, thereby playing a role in inhibiting breast cancer. Therefore, the loss of response in epithelial cells that leads to the inhibition of cell proliferation due to TGF-β is a landmark event in tumorigenesis. As tumors progress, TGF-β can promote tumor cell invasion, metastasis, and drug resistance. At present, the above-mentioned role of TGF-β is related to the interaction of multiple signaling pathways in the cell, which can attenuate or abolish the inhibition of proliferation and apoptosis-promoting effects of TGF-β and enhance its promotion of tumor progression. This article focuses on the molecular mechanisms through which TGF-β interacts with multiple intracellular signaling pathways in tumor progression and the effects of these interactions on tumorigenesis.
Insights
Transforming growth factor-beta (TGF-β) initially inhibits cancer but later promotes tumor invasion and metastasis. This study explores how TGF-β interacts with cellular pathways to drive tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Transforming growth factor-beta (TGF-β) signaling is crucial in cancer development.
- TGF-β initially inhibits epithelial cell growth and proliferation, acting as a tumor suppressor.
- Loss of TGF-β responsiveness is a key event in tumorigenesis, while advanced tumors utilize TGF-β to promote invasion and metastasis.
Purpose of the Study:
- To investigate the molecular mechanisms underlying TGF-β's dual role in cancer.
- To elucidate how TGF-β interacts with intracellular signaling pathways during tumor progression.
- To understand how these interactions influence tumorigenesis and metastasis.
Main Methods:
- Review of current literature on TGF-β signaling in cancer.
- Analysis of molecular interactions between TGF-β and other cellular pathways.
- Focus on mechanisms driving tumor cell invasion, metastasis, and drug resistance.
Main Results:
- TGF-β exhibits context-dependent roles in cancer, shifting from tumor suppression to tumor promotion.
- Interactions with multiple intracellular pathways can override TGF-β's anti-proliferative effects.
- These complex interactions enhance TGF-β's pro-tumorigenic activities, including invasion and metastasis.
Conclusions:
- TGF-β signaling is a critical regulator of tumorigenesis, with a complex interplay of pathways.
- Understanding these molecular interactions is key to developing targeted cancer therapies.
- The dual role of TGF-β highlights the intricate nature of cancer progression and therapeutic resistance.
Related Concept Videos
10:37Induction and Analysis of Epithelial to Mesenchymal Transition
11:42Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
11:48Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

